OBJECTIVES: To report on the cumulative proportion of deaths occurring within 3 months of starting antiretroviral treatment (ART) and to identify factors associated with such deaths, among adults at primary health centres in a rural district of Malawi. METHODS: Retrospective cohort study: from June 2006 to April 2008, deaths occurring over a 3-month period were determined and risk factors examined. RESULTS: A total of 2316 adults (706 men and 1610 women; median age 35 years) were included in the analysis and followed up for a total of 1588 person-years (PY); 277 (12%) people died, of whom 206 (74%) people died within 3 months of initiating ART (cumulative incidence: 13.0; 95% confidence interval: 11.3-14.8 per 100 PY of follow-up). Significant risk factors associated with early deaths included male sex, WHO stage 4 disease, oesophageal or persistent oral candidiasis and unexplained presumed or measured weight loss >10%. One in every 3 patients who either died or was lost to follow up had unexplained weight loss >10%, and survival in this group was significantly different from patients without this condition. CONCLUSIONS: Seven in 10 individuals initiating ART at primary health centres die early. Specific groups of patients are at higher risk of such mortality and should receive priority attention, care and support.
OBJECTIVES: To report on the cumulative proportion of deaths occurring within 3 months of starting antiretroviral treatment (ART) and to identify factors associated with such deaths, among adults at primary health centres in a rural district of Malawi. METHODS: Retrospective cohort study: from June 2006 to April 2008, deaths occurring over a 3-month period were determined and risk factors examined. RESULTS: A total of 2316 adults (706 men and 1610 women; median age 35 years) were included in the analysis and followed up for a total of 1588 person-years (PY); 277 (12%) people died, of whom 206 (74%) people died within 3 months of initiating ART (cumulative incidence: 13.0; 95% confidence interval: 11.3-14.8 per 100 PY of follow-up). Significant risk factors associated with early deaths included male sex, WHO stage 4 disease, oesophageal or persistent oral candidiasis and unexplained presumed or measured weight loss >10%. One in every 3 patients who either died or was lost to follow up had unexplained weight loss >10%, and survival in this group was significantly different from patients without this condition. CONCLUSIONS: Seven in 10 individuals initiating ART at primary health centres die early. Specific groups of patients are at higher risk of such mortality and should receive priority attention, care and support.
Authors: Matthew P Fox; Kate Shearer; Mhairi Maskew; William Macleod; Pappie Majuba; Patrick Macphail; Ian Sanne Journal: AIDS Date: 2012-09-10 Impact factor: 4.177
Authors: Morna Cornell; Anna Grimsrud; Lara Fairall; Matthew P Fox; Gilles van Cutsem; Janet Giddy; Robin Wood; Hans Prozesky; Lerato Mohapi; Claire Graber; Matthias Egger; Andrew Boulle; Landon Myer Journal: AIDS Date: 2010-09-10 Impact factor: 4.177
Authors: Christopher J Hoffmann; Katherine L Fielding; Victoria Johnston; Salome Charalambous; Craig Innes; Richard D Moore; Richard E Chaisson; Alison D Grant; Gavin J Churchyard Journal: J Acquir Immune Defic Syndr Date: 2011-11-01 Impact factor: 3.731
Authors: Gretchen L Birbeck; Michelle P Kvalsund; Peter A Byers; Richard Bradbury; Charles Mang'ombe; Natalie Organek; Trevor Kaile; Alex M Sinyama; Sylvester S Sinyangwe; Kennedy Malama; Costantine Malama Journal: Am J Trop Med Hyg Date: 2011-10 Impact factor: 2.345
Authors: Katharina Kranzer; Jennifer Zeinecker; Philip Ginsberg; Catherine Orrell; Nosindiso N Kalawe; Stephen D Lawn; Linda-Gail Bekker; Robin Wood Journal: PLoS One Date: 2010-11-02 Impact factor: 3.240
Authors: Nuala McGrath; Judith R Glynn; Jacqueline Saul; Katharina Kranzer; Andreas Jahn; Frank Mwaungulu; Msenga H C Ngwira; Hazzie Mvula; Fipson Munthali; Venance Mwinuka; Lorren Mwaungulu; Paul E M Fine; Amelia C Crampin Journal: BMC Public Health Date: 2010-10-12 Impact factor: 3.295
Authors: Erin E McClelland; Letizia M Hobbs; Johanna Rivera; Arturo Casadevall; Wayne K Potts; Jennifer M Smith; Jeramia J Ory Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240
Authors: A Sarah Walker; Andrew J Prendergast; Peter Mugyenyi; Paula Munderi; James Hakim; Addy Kekitiinwa; Elly Katabira; Charles F Gilks; Cissy Kityo; Patricia Nahirya-Ntege; Kusum Nathoo; Diana M Gibb Journal: Clin Infect Dis Date: 2012-09-12 Impact factor: 9.079